Gauging the Impact of High-Impact Drugs in Workers’ Comp

September 11, 2024

New Trends in Opioids and Pain Management

August 7, 2024

Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.

Why Telephonic Case Management Is Not One-Size-Fits-All

July 17, 2024

Discover how partnering with a tailored telephonic case management (TCM) program can enhance return-to-work outcomes. Hear from Dawn Moore on assessing and customizing TCM programs to meet unique client needs in this insightful podcast episode.

Return-to-work strategies for LGBTQ+ Injured Employees

June 25, 2024

Celebrate Pride Month by reflecting on the progress of LGBTQ+ equality and addressing health care disparities. Join Genex case manager Chikita Mann, MSN, RN, CCM, as she explores this crucial topic.

Cool Tips for Beating the Heat at Work

June 4, 2024

Summer’s finally here and, as the weather warms up, it also creates some real issues for employees across the U.S. To talk about this issue in more detail, Melissa Martinez, RN, BSN, clinical operations manager of Enlyte’s ClinicalCare24 program, offers strategies to prevent and treat heat-related issues on the job

Safe at Home: Managing the Provider Shortage in Home Health

April 16, 2024

Tune into this podcast where Nicole Usher delves into the effects of the provider shortage on home health care.

Combatting New Jersey Auto Casualty Challenges

March 11, 2024

When an auto injury occurs, insurers often face challenges in coordinating with multiple vendors to address the claim. This is especially true in New Jersey, which has strict requirements that every insurer needs to meet. To discuss this issue, and offer solutions for handling it, is Ben Roberts, vice president, utilization review of Genex.